HealthcareServices

Stem Cell/Cord Blood Banking Market Growth Projection: Expected to Surpass $24.47 Billion by 2030 at 13% CAGR

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the stem cell/cord blood banking market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Stem Cell/Cord Blood Banking Market be in 2030 compared with 2026?

The stem cell/cord blood banking market size has expanded quickly in recent years. This market is set to increase from $13.33 billion in 2025 to $15.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be attributed to several factors, including a rise in private banking adoption, enhanced medical awareness, improvements in storage technologies, the establishment of regulatory frameworks, and various marketing initiatives.

The stem cell/cord blood banking market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $24.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This projected growth throughout the forecast period stems from factors such as broader therapeutic applications, enhanced affordability, increased entry into developing markets, collaborations with healthcare facilities, and a rising need for extended storage. Key trends anticipated during this period encompass the rise in private cord blood storage, the emergence of hybrid public-private banking frameworks, wider applications for stem cells, advancements in cryogenic storage methods, and initiatives to increase consumer awareness.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2514&type=smp

What Drivers Are Guiding Growth Patterns In The Stem Cell/Cord Blood Banking Market?

The increasing incidence of long-term illnesses is anticipated to drive the expansion of the stem cell/cord blood banking market moving ahead. A chronic disease is defined as a type of ailment persisting for three months or more and capable of worsening over time. Given that chronic conditions frequently lack efficient remedies, the restorative capabilities of stem cells and cord blood are being progressively investigated for medical applications. The growth in stem cell transplantation, individualized medicine, and clinical studies exploring new treatments for chronic ailments is collectively generating an elevated need for banking provisions. For example, in February 2024, the World Health Organization, an intergovernmental entity situated in Switzerland, projected that by 2050, more than 35 million new cancer cases would arise, marking a 77% surge from the estimated 20 million cases recorded in 2022. Consequently, the expanding occurrence of chronic illnesses is fueling the development of the stem cell or cord blood banking market.

Which Segments Are Driving Activity In The Stem Cell/Cord Blood Banking Market?

The stem cell/cord blood banking market covered in this report is segmented –

1) By Cell Type: Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells

2) By Service: Collection, Processing, Analysis, Storage

3) By Bank Type: Public, Private

4) By Application: Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications

Subsegments:

1) By Adult Stem Cells: Hematopoietic Stem Cells (HSC), Mesenchymal Stem Cells (MSC), Neural Stem Cells (NSC), Induced Pluripotent Stem Cells (iPSCs)

2) By Umbilical Cord Blood Stem Cells: Hematopoietic Stem Cells (HSC) From Cord Blood, Mesenchymal Stem Cells (MSC) From Cord Blood

3) By Embryonic Stem Cells: Embryonic Stem Cells (ESCs) From Human Embryos, Stem Cells Derived From Human Embryonic Germ Cells

How Are Emerging Trends Affecting The Progression Of The Stem Cell/Cord Blood Banking Market?

Leading companies within the stemcell/cord blood banking market are developing peripheral blood stem cell processing and storage services to gain a competitive edge. This process involves the collection, processing, testing, and cryopreservation of haematopoietic stem cells (HSCs) sourced from a patient’s peripheral blood. For instance, in February 2023, Cordlife Group Limited, a Singapore-based healthcare company, introduced a new peripheral blood stem cell (PBSC) processing and storage service in Singapore. This service aims to support patients who require haematopoietic stem cell transplantation for various blood-related conditions, such as leukemia, myeloma, and lymphoma. Cordlife’s partnership with the Centre for Clinical Haematology (CFCH) facilitates stem cell mobilization and harvesting for eligible patients, with Cordlife then managing the subsequent processing, testing, and cryopreservation of the PBSCs. The introduction of this new service is intended to improve treatment outcomes for individuals needing haematopoietic stem cell transplants and expand Cordlife’s banking service portfolio in Singapore.

Which Major Industry Participants Are Leading The Stem Cell/Cord Blood Banking Market Growth?

Major companies operating in the stem cell/cord blood banking market are Cryo-Cell International Inc, Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Ltd, CordVida, Cryo Stemcell, ReeLabs Pvt Ltd, Smart Cells International Ltd, Stemade Biotech Pvt Ltd, ViaCord Inc, LifeCell International, Cryoviva Biotech Pvt Ltd, Cord Blood America Inc, StemCyte Inc, Cord Blood Registry Systems Inc, Healthbanks Biotech Usa Inc, Cryo-save Private Ltd, New York Cord Blood Center, CryoHoldco, Vita 34 International AG, Reliance Life Sciences Pvt Ltd, Maze Cord Blood Laboratories, Cells4Life Group LLP

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Stem Cell/Cord Blood Banking Market?

North America was the largest region in the stem cell/cord blood banking market in 2025. Western Europe was the second largest region in the stem cell/cord blood banking market analysis. The regions covered in the stem cell/cord blood banking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Stem Cell/Cord Blood Banking Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2514&type=smp

Browse Through More Reports Similar to the Global Stem Cell/Cord Blood Banking Market 2026, By The Business Research Company

Blood Collection Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Blood Bank Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795